Stock Market Reviews

ELV (Elevance Health, Inc.) News

Get the latest news, insights, and market updates on ELV (Elevance Health, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Circle Internet initiated, Lyft downgraded: Wall Street's top analyst calls
  Circle Internet initiated, Lyft downgraded: Wall Street's top analyst calls
  Dec 19, 2025 - $ELV
• Democrats Pounce as Congress Allows Obamacare Premiums to Spike
  Health care premiums for more than 20 million Americans will, on average, more than double in 2026, which risks putting insurance out of reach for many voters already concerned about the costs of housing, groceries, utilities and other expenses. When lawmakers return to the Capitol next month, they have less than two weeks to resolve the issue before open enrollment ends Jan. 15. Amid fierce Republican infighting, Democrats are already declaring victory.
  Dec 19, 2025 - $ELV
• Health Insurer Stocks Spooked as Trump Asks for Lower Premiums
  At Friday’s news conference announcing the latest drug-pricing deals, Trump said he wants health insurers to ‘ease up and start cutting prices’ as well.
  Dec 19, 2025 - $ELV
• JPMorgan Reinstates Palo Alto Networks (PANW) With Overweight Rating
  Palo Alto Networks, Inc. (NASDAQ:PANW) is included among the 12 Best Long Term US Stocks to Buy Now. On December 17, JPMorgan reinstated coverage of Palo Alto Networks, Inc. (NASDAQ:PANW) with an Overweight rating and a $235 price target. The move followed a period of restriction. The firm said Palo Alto offers one of the […]
  Dec 18, 2025 - $ELV
• BofA Adjusts Elevance Health (ELV) Target to Reflect Higher Sector Valuations
  Elevance Health, Inc. (NYSE:ELV) is included among the 12 Best Long Term US Stocks to Buy Now. On December 16, BofA lifted its price target on Elevance Health, Inc. (NYSE:ELV) to $385 from $370 and kept a Neutral rating. The firm noted that its higher target reflects richer multiples across the peer group. Elevance Health, […]
  Dec 18, 2025 - $ELV
• Wall Street Sees an 18% Upside to Elevance Health (ELV)
  Elevance Health, Inc. (NYSE:ELV) is one of the best stocks to buy according to Seth Klarman. As of December 12, the average price target for ELV suggests an upside of 10%; however, the Street high indicates an upside of 18%. According to Klarman’s 13F portfolio, the billionaire holds a $426 million stake in Elevance Health […]
  Dec 17, 2025 - $ELV
• Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026
  Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.
  Dec 17, 2025 - $ELV
• Insiders At Elevance Health Sold US$3.5m In Stock, Alluding To Potential Weakness
  Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which may...
  Dec 16, 2025 - $ELV
• Winners And Losers Of Q3: Elevance Health (NYSE:ELV) Vs The Rest Of The Health Insurance Providers Stocks
  As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Elevance Health (NYSE:ELV) and its peers.
  Dec 16, 2025 - $ELV
• AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries
  OLDWICK, N.J., December 12, 2025--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV], as well as most of its non-Blue-branded subsidiaries. In addition, AM Best has upgraded the FSR to A (Excellent) from A- (Excellent) and the Long-Term ICR to "a+" (Excellent)
  Dec 12, 2025 - $ELV